Gilead Sciences, Inc. (BIT:1GILD)
Italy · Delayed Price · Currency is EUR 131.38
+5.32 (4.22%)
At close: Feb 11, 2026
Gilead Sciences Market Cap
Gilead Sciences has a market cap or net worth of €162.91 billion as of February 11, 2026. Its market cap has increased by 43.98% in one year.
Market Cap
162.91B
Enterprise Value
174.70B
Revenue
25.08B
Ranking
n/a
PE Ratio
22.48
Stock Price
€131.38
Market Cap Chart
Since January 22, 1992, Gilead Sciences's market cap has increased from 194.48M to 162.91B, an increase of 83,668.23%. That is a compound annual growth rate of 21.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 153.49B | 18.35% |
| Dec 31, 2025 | 129.70B | 16.64% |
| Dec 31, 2024 | 111.19B | 21.76% |
| Dec 29, 2023 | 91.32B | -9.36% |
| Dec 30, 2022 | 100.75B | 25.80% |
| Dec 31, 2021 | 80.09B | 34.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 9.66B |
| DiaSorin | 3.96B |
| Amplifon | 3.05B |
| EL.En. | 1.14B |
| Safilo Group | 869.90M |
| Philogen | 853.60M |
| Pharmanutra | 597.32M |
| Garofalo Health Care | 489.36M |